5-Amino-1,6-dihydro-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one
AlkaPlorer ID: AK005179
Synonym: 8-Azaguanine, Guanazole, Pathocidin, NSC 749, SF 337, Antibiotic SF 337, Azan
IUPAC Name: 5-amino-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one
Structure
SMILES: N=C1NC(=O)C2=C(NN=N2)N1
InChI: InChI=1S/C4H4N6O/c5-4-6-2-1(3(11)7-4)8-10-9-2/h(H4,5,6,7,8,9,10,11)
InChIKey: LPXQRXLUHJKZIE-UHFFFAOYSA-N
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|---|---|---|---|---|---|---|
| Streptomyces morookaense | Streptomyces | Streptomycetaceae | Kitasatosporales | Actinomycetes | Actinomycetota | None | Bacteria |
| Streptomyces albus | Streptomyces | Streptomycetaceae | Kitasatosporales | Actinomycetes | Actinomycetota | None | Bacteria |
Properties Information
Molecule Weight: 152.11700000000002
TPSA?: 114.07
MolLogP?: -1.5462300000000004
Number of H-Donors: 4
Number of H-Acceptors: 4
RingCount: 2
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Chlorocebus sabaeus | Vero C1008 | CC50 | 10380.0 | nM | 10.6019/CHEMBL4495565 |
| Chlorocebus sabaeus | Vero C1008 | CC50 | 11210.0 | nM | 10.6019/CHEMBL4495565 |
| Chlorocebus sabaeus | Vero C1008 | CC50 | 23700.0 | nM | 10.6019/CHEMBL4651402 |
| Chlorocebus sabaeus | Vero C1008 | pCC50 | 4.63 | None | 10.6019/CHEMBL4651402 |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 7943.3 | nM | None |
| Homo sapiens | 786-0 | GI50 | 292.42 | nM | None |
| Homo sapiens | A498 | GI50 | 11587.77 | nM | None |
| Homo sapiens | A549 | GI50 | 32960.97 | nM | None |
| Homo sapiens | ACHN | GI50 | 16330.52 | nM | None |
| Homo sapiens | Arachidonate 15-lipoxygenase | Potency | 3.2 | nM | None |
| Homo sapiens | Ataxin-2 | Potency | 631.0 | nM | None |
| Homo sapiens | Breast cancer type 1 susceptibility protein | Potency | 11220.2 | nM | None |
| Homo sapiens | BT-549 | GI50 | 473.15 | nM | None |
| Homo sapiens | CAKI-1 | GI50 | 304.09 | nM | None |
| Homo sapiens | CCRF-CEM | GI50 | 242.1 | nM | None |
| Homo sapiens | Cellular tumor antigen p53 | Potency | 10000.0 | nM | None |
| Homo sapiens | COLO 205 | GI50 | 13304.54 | nM | None |
| Homo sapiens | Cytochrome P450 1A2 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | AC50 | nan | None | None |
| Homo sapiens | DLD-1 | GI50 | 19998.62 | nM | None |
| Homo sapiens | DMS-114 | GI50 | 6501.3 | nM | None |
| Homo sapiens | DMS-273 | GI50 | 633.87 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3F | Potency | 3527.7 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3F | Potency | 3958.2 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3F | Potency | 6513.1 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3F | Potency | 9200.0 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3G | Potency | 1584.9 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3G | Potency | 3162.3 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3G | Potency | 3958.2 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3G | Potency | 5173.5 | nM | None |
| Homo sapiens | DNA dC->dU-editing enzyme APOBEC-3G | Potency | 18356.4 | nM | None |
| Homo sapiens | DNA polymerase iota | Potency | 100000.0 | nM | None |
| Homo sapiens | DU-145 | GI50 | 683.91 | nM | None |
| Homo sapiens | EKVX | GI50 | 11350.11 | nM | None |
| Homo sapiens | Geminin | Potency | 290.9 | nM | None |
| Homo sapiens | Geminin | Potency | 14581.0 | nM | None |
| Homo sapiens | Glycoprotein hormones alpha chain | Potency | 2818.4 | nM | None |
| Homo sapiens | HCC 2998 | GI50 | 19230.92 | nM | None |
| Homo sapiens | HCT-116 | GI50 | 881.05 | nM | None |
| Homo sapiens | HCT-15 | GI50 | 23988.33 | nM | None |
| Homo sapiens | Hemoglobin beta chain | Potency | 794.3 | nM | None |
| Homo sapiens | Hemoglobin beta chain | Potency | 2511.89 | nM | None |
| Homo sapiens | HEp-2 | IC50 | 2000.0 | nM | 10.1021/jm00364a023 |
| Homo sapiens | HEp-2 | IC50 | nan | nM | 10.1021/jm00364a023 |
| Homo sapiens | HepG2 | IC50 relative | 7500.0 | nM | 10.6019/EOS300108 |
| Homo sapiens | Histone acetyltransferase GCN5 | Potency | 89.1 | nM | None |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -13.26 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -2.94 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | HL-60 | GI50 | 325.84 | nM | None |
| Homo sapiens | HOP-18 | GI50 | 338.84 | nM | None |
| Homo sapiens | HOP-62 | GI50 | 325.84 | nM | None |
| Homo sapiens | HOP-92 | GI50 | 756.83 | nM | None |
| Homo sapiens | Hs-578T | GI50 | 905.73 | nM | None |
| Homo sapiens | HT-29 | GI50 | 26121.61 | nM | None |
| Homo sapiens | Hypoxanthine-guanine phosphoribosyltransferase | Km | 72000.0 | nM | 10.1021/jm061012j |
| Homo sapiens | Hypoxanthine-guanine phosphoribosyltransferase | Km(app) | nan | None | 10.1021/jm061012j |
| Homo sapiens | Hypoxia-inducible factor 1 alpha | Potency | 7943.3 | nM | None |
| Homo sapiens | IGROV-1 | GI50 | 63826.35 | nM | None |
| Homo sapiens | Isocitrate dehydrogenase [NADP] cytoplasmic | Potency | 517.4 | nM | None |
| Homo sapiens | K562 | GI50 | 267.92 | nM | None |
| Homo sapiens | KM12 | GI50 | 34119.29 | nM | None |
| Homo sapiens | KM-20L2 | GI50 | 9204.5 | nM | None |
| Homo sapiens | LOX IMVI | GI50 | 223.36 | nM | None |
| Homo sapiens | LXFL 529 | GI50 | 16292.96 | nM | None |
| Homo sapiens | M14 | GI50 | 291.74 | nM | None |
| Homo sapiens | M19-MEL | GI50 | 1137.63 | nM | None |
| Homo sapiens | Malme-3M | GI50 | 352.37 | nM | None |
| Homo sapiens | MCF7 | GI50 | 40831.94 | nM | None |
| Homo sapiens | MDA-MB-231 | GI50 | 5821.03 | nM | None |
| Homo sapiens | MDA-MB-435 | GI50 | 265.46 | nM | None |
| Homo sapiens | MDA-N | GI50 | 308.32 | nM | None |
| Homo sapiens | Microphthalmia-associated transcription factor | AC50 | 875.0 | nM | None |
| Homo sapiens | MOLT-4 | GI50 | 272.27 | nM | None |
| Homo sapiens | Monoamine oxidase A | Activity | nan | None | 10.1021/jm800656v |
| Homo sapiens | Monoamine oxidase B | Activity | nan | None | 10.1021/jm800656v |
| Homo sapiens | Mothers against decapentaplegic homolog 3 | Potency | 8912.5 | nM | None |
| Homo sapiens | Mothers against decapentaplegic homolog 3 | Potency | 15848.9 | nM | None |
| Homo sapiens | NCI/ADR-RES | GI50 | 1931.97 | nM | None |
| Homo sapiens | NCI-H226 | GI50 | 788.86 | nM | None |
| Homo sapiens | NCI-H23 | GI50 | 25118.86 | nM | None |
| Homo sapiens | NCI-H322M | GI50 | 20941.12 | nM | None |
| Homo sapiens | NCI-H460 | GI50 | 11350.11 | nM | None |
| Homo sapiens | NCI-H522 | GI50 | 13899.53 | nM | None |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 29092.9 | nM | None |
| Homo sapiens | OVCAR-3 | GI50 | 16032.45 | nM | None |
| Homo sapiens | OVCAR-4 | GI50 | 12882.5 | nM | None |
| Homo sapiens | OVCAR-5 | GI50 | 21928.05 | nM | None |
| Homo sapiens | OVCAR-8 | GI50 | 550.81 | nM | None |
| Homo sapiens | PC-3 | GI50 | 855.07 | nM | None |
| Homo sapiens | Probable global transcription activator SNF2L2 | EC50 | 91170.0 | nM | None |
| Homo sapiens | Purine nucleoside phosphorylase | Inhibition | 16.0 | % | 10.1021/jm00207a008 |
| Homo sapiens | RPMI-8226 | GI50 | 233.88 | nM | None |
| Homo sapiens | RXF 393 | GI50 | 142.89 | nM | None |
| Homo sapiens | SF-268 | GI50 | 406.44 | nM | None |
| Homo sapiens | SF-295 | GI50 | 3111.72 | nM | None |
| Homo sapiens | SF-539 | GI50 | 360.58 | nM | None |
| Homo sapiens | SK-MEL-2 | GI50 | 73.96 | nM | None |
| Homo sapiens | SK-MEL-28 | GI50 | 727.78 | nM | None |
| Homo sapiens | SK-MEL-5 | GI50 | 748.17 | nM | None |
| Homo sapiens | SK-OV-3 | GI50 | 1039.92 | nM | None |
| Homo sapiens | SN12C | GI50 | 334.2 | nM | None |
| Homo sapiens | SNB-19 | GI50 | 42657.95 | nM | None |
| Homo sapiens | SNB-75 | GI50 | 1538.15 | nM | None |
| Homo sapiens | SNB-78 | GI50 | 1016.25 | nM | None |
| Homo sapiens | SR | GI50 | 2421.03 | nM | None |
| Homo sapiens | SW-620 | GI50 | 306.2 | nM | None |
| Homo sapiens | T47D | GI50 | 3443.5 | nM | None |
| Homo sapiens | Thyroid hormone receptor beta-1 | Potency | 79432.8 | nM | None |
| Homo sapiens | TK-10 | GI50 | 408.32 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 1995.3 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 6309.6 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 7307.8 | nM | None |
| Homo sapiens | U-251 | GI50 | 1741.81 | nM | None |
| Homo sapiens | UACC-257 | GI50 | 734.51 | nM | None |
| Homo sapiens | UACC-62 | GI50 | 371.54 | nM | None |
| Homo sapiens | UO-31 | GI50 | 365.59 | nM | None |
| Mus musculus | P388 | ILS | nan | None | 10.1021/jm00364a023 |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 6600.0 | nM | 10.1021/jm061012j |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 18000.0 | nM | 10.1021/jm061012j |
| Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG12228) | Transcriptional activator protein lasR | IC50 | 640.0 | nM | 10.1021/acs.jmedchem.8b00540 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 0.5206 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 4.66 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 3720.0 | nM | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 10340.0 | nM | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 50100.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 50118.72 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 relative | 3.896 | uM | 10.6019/EOS300033 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -3.42 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 12.22 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 12.58 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition index | -0.08084 | None | 10.1101/2020.04.03.023846 |
| None | ADMET | Selectivity index | 1.08 | None | 10.6019/CHEMBL4495565 |
| None | ADMET | Selectivity index | 2.79 | None | 10.6019/CHEMBL4495565 |
| None | No relevant target | EC50 | 91170.0 | nM | None |
| None | Unchecked | EC50 | 100.0 | nM | None |
| None | Unchecked | EC50 | 153.0 | nM | None |
| None | Unchecked | EC50 | 10345.0 | nM | None |
| None | Unchecked | IC50 | 2560.0 | nM | None |
| None | Unchecked | IC50 | 5000.0 | nM | None |
| None | Unchecked | IC50 | 21000.0 | nM | None |
| None | Unchecked | IC50 | 80000.0 | nM | None |
| None | Unchecked | Km | 12600.0 | nM | 10.1021/jm061012j |
| None | Unchecked | Km | 26600.0 | nM | 10.1021/jm061012j |
| None | Unchecked | Potency | 115.8 | nM | None |
| None | Unchecked | Potency | 707.9 | nM | None |
| None | Unchecked | Potency | 10000.0 | nM | None |
| None | Unchecked | Potency | 22387.2 | nM | None |
| None | Unchecked | Potency | 28183.8 | nM | None |
